Lastest Stories by Trey Thoelcke

Interest in almost all of the most heavily shorted stocks traded on the New York Stock Exchange shrank between the February 29 and March 15 settlement dates. Except for Pfizer, that is.
Interest in the most heavily shorted stocks traded on the Nasdaq rose, for the most part, between the February 29 and March 15 settlement dates. Leading that trend was Intel.
Most of the stocks traded on the New York Stock Exchange with the greatest number of shares short saw their short interest decline between the February 12 and February 29 settlement dates.
Many of the most heavily shorted stocks traded on the Nasdaq saw their short interest dwindle between the February 12 and February 29 settlement dates. Yet a few stocks bucked that trend.
The short interest in Apple's stock fell nearly 10% early in the month, which is odd given the ongoing negative sentiment about stock.
The most shorted stock traded on the New York Stock Exchange — Chesapeake Energy — bucked the short interest trend with a modest gain in February.
When it came to the most heavily shorted stocks traded on the Nasdaq, short sellers appeared to be remain cautious.
AstraZeneca has announced that the European Commission granted marketing authorization for two of its treatments: Zurampic for gout and Brilique for heart attack patients.
Ahead of its fourth-quarter earnings report this week, Nordstrom has announced the expansion of its footprint in Canada.
Baxalta is scheduled to report fourth-quarter and full-year results before markets open on Tuesday.
The short interest in Apple's stock fell more than 3% in the latter weeks of last month, and Apple remains one of the most shorted Nasdaq-traded stocks.
Among the six most heavily shorted stocks traded on the New York Stock Exchange, short sellers continued to pile on Alcoa and Freeport-McMoRan between the January 15 and January 29 settlement dates.
Bucking the short interest trend in late January were Frontier Communications, MannKind and Groupon.
Coca-Cola is scheduled to report its fourth-quarter financial results before the markets open on Tuesday.
Among the most heavily shorted stocks traded on the Nasdaq, the movement was mostly positive though mostly mild in early January.